Cryptocurrencies
Pfizer’s newer medicines carry more weight in Q1
Pfizer’s first-quarter results gave investors a clearer view of how much work the drugmaker’s newer portfolio is doing as the company continues moving away from its pandemic-era sales base. In a report given to TheStreet, Read more…